Home
Conditions
Leukemia, Prolymphocytic

Clinical trial condition

Leukemia, Prolymphocytic

Explore clinical trials studying Leukemia, Prolymphocytic. Study availability and eligibility vary by location and protocol.

124 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Prolymphocytic trial results

Active, not recruiting

PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia

NCT01589302

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Active, not recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

NCT01231412

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
Locations: University of Colorado Denver, Colorado, United States

Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

NCT00364286

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL

NCT02296918

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: Research Site Columbus, Ohio, United States

View Trial Details

Completed

Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL

NCT02005289

Conditions: Chronic Disease, Contiguous Stage II Small Lymphocytic Lymphoma, Disease Attributes, +26 more
Locations: The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

NCT04191187

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

NCT02722668

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, +74 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma

NCT02303392

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Leukemia, Prolymphocytic

Leukemia, Prolymphocytic trial results

Related conditions